110 related articles for article (PubMed ID: 11510971)
21. Prognostic significance of progesterone receptor immunohistochemistry for lymph node metastases in endometrial carcinoma.
Iwai K; Fukuda K; Hachisuga T; Mori M; Uchiyama M; Iwasaka T; Sugimori H
Gynecol Oncol; 1999 Mar; 72(3):351-9. PubMed ID: 10053107
[TBL] [Abstract][Full Text] [Related]
22. Expression of integrins αvβ3 and αvβ5 and their ligands in primary and secondary central nervous system neoplasms.
Mittelbronn M; Warth A; Meyermann R; Goodman S; Weller M
Histol Histopathol; 2013 Jun; 28(6):749-58. PubMed ID: 23238957
[TBL] [Abstract][Full Text] [Related]
23. Of humans and canines: Immunohistochemical analysis of PCNA, Bcl-2, p53, cytokeratin and ER in mammary tumours.
Kumaraguruparan R; Prathiba D; Nagini S
Res Vet Sci; 2006 Oct; 81(2):218-24. PubMed ID: 16740286
[TBL] [Abstract][Full Text] [Related]
24. Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer.
Ebina M; Steinberg SM; Mulshine JL; Linnoila RI
Cancer Res; 1994 May; 54(9):2496-503. PubMed ID: 7909277
[TBL] [Abstract][Full Text] [Related]
25. Simian virus 40 large tumor antigen forms specific complexes with p53 and pRb in human brain tumors.
Zhen H; Zhang X; Zhang Z; Fei Z; He X; Liang J; Huang W; Liu X; Zhang P
Chin Med J (Engl); 2001 Apr; 114(4):382-6. PubMed ID: 11780459
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical expression of p53 protein and proliferating cell nuclear antigen in hepatocellular carcinoma.
Nakopoulou L; Janinis J; Giannopoulou I; Lazaris AC; Koureas A; Zacharoulis D
Pathol Res Pract; 1995 Dec; 191(12):1208-13. PubMed ID: 8927568
[TBL] [Abstract][Full Text] [Related]
27. [Formation of specific complex of SV40 large tumor antigen and p53 in human brain tumors].
Zhen H; Zhang X; Bu X
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Mar; 15(1):73-6. PubMed ID: 12526309
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical expression of metallothionein in benign premalignant and malignant epithelium of the larynx: correlation with p53 and proliferative cell nuclear antigen.
Ioachim E; Assimakopoulos D; Peschos D; Zissi A; Skevas A; Agnantis NJ
Pathol Res Pract; 1999; 195(12):809-14. PubMed ID: 10631715
[TBL] [Abstract][Full Text] [Related]
29. The value of immunohistochemical research on PCNA, p53 and heat shock proteins in prostate cancer management: a review.
Cappello F; Ribbene A; Campanella C; Czarnecka AM; Anzalone R; Bucchieri F; Palma A; Zummo G
Eur J Histochem; 2006; 50(1):25-34. PubMed ID: 16584982
[TBL] [Abstract][Full Text] [Related]
30. [Expression of P21 WAF1/CIP1 in human astrocytomas in correlating with P53, MDM2, and cellular proliferation index].
Xu QZ; Liu F; Lu DH; Yu SZ; Yang H
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug; 23(4):341-5. PubMed ID: 12940073
[TBL] [Abstract][Full Text] [Related]
31. Correlated expression of BCL-2 protein, estrogen receptor, cathepsin D and low growth fraction (PCNA) in intracystic papillary breast carcinoma.
Lanzafame S; Emmanuele C; Torrisi A; Magro G
Pathol Res Pract; 1998; 194(8):541-7. PubMed ID: 9779488
[TBL] [Abstract][Full Text] [Related]
32. Comparative evaluation of p53-protein expression and the PCNA and Ki-67 proliferating cell indices in human astrocytomas.
Kordek R; Biernat W; Debiec-Rychter M; Alwasiak J; Liberski PP
Pathol Res Pract; 1996 Mar; 192(3):205-9. PubMed ID: 8739466
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors in astrocytomas: relationship of p53, MDM-2, BCL-2 and PCNA immunohistochemical expression to tumor grade and overall patient survival.
Ehrmann J; Kolár Z; Vojtĕsek B; Kala M; Komenda S; Oulton A
Neoplasma; 1997; 44(5):299-304. PubMed ID: 9473789
[TBL] [Abstract][Full Text] [Related]
34. The expression of the proliferating antigen Ki67, PCNA and products of suppressor gene p53 in primary invasive ductal breast carcinoma.
Niewiadomska H; Jeziorski A; Olborski B
J Exp Clin Cancer Res; 1998 Dec; 17(4):503-10. PubMed ID: 10089075
[TBL] [Abstract][Full Text] [Related]
35. [The expression of proliferating cell nuclear antigen and p53 protein in salivary gland tumours].
Tian Y; Wang Z; Zhong M
Zhonghua Kou Qiang Yi Xue Za Zhi; 1997 May; 32(3):177-9. PubMed ID: 10680534
[TBL] [Abstract][Full Text] [Related]
36. Loss of p21WAF1/Cip1 protein expression accompanies progression of sporadic colorectal neoplasms but not hereditary nonpolyposis colorectal cancers.
Sinicrope FA; Roddey G; Lemoine M; Ruan S; Stephens LC; Frazier ML; Shen Y; Zhang W
Clin Cancer Res; 1998 May; 4(5):1251-61. PubMed ID: 9607584
[TBL] [Abstract][Full Text] [Related]
37. Down-regulation of tumor suppressor gene PTEN, overexpression of p53, plus high proliferating cell nuclear antigen index predict poor patient outcome of hepatocellular carcinoma after resection.
Hu TH; Wang CC; Huang CC; Chen CL; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Tai MH
Oncol Rep; 2007 Dec; 18(6):1417-26. PubMed ID: 17982625
[TBL] [Abstract][Full Text] [Related]
38. Correlation between proliferating cell nuclear antigen and p53 protein expression and 5-year survival rate in nasopharyngeal carcinoma.
Wang LF; Chai CY; Kuo WR; Tai CF; Lee KW; Ho KY
Am J Otolaryngol; 2006; 27(2):101-5. PubMed ID: 16500472
[TBL] [Abstract][Full Text] [Related]
39. Distinctive immunohistochemical profiles of small heat shock proteins (heat shock protein 27 and alpha B-crystallin) in human brain tumors.
Hitotsumatsu T; Iwaki T; Fukui M; Tateishi J
Cancer; 1996 Jan; 77(2):352-61. PubMed ID: 8625245
[TBL] [Abstract][Full Text] [Related]
40. Human non-small cell lung cancer: p53 protein accumulation is an early event and persists during metastatic progression.
Fontanini G; Vignati S; Bigini D; Merlo GR; Ribecchini A; Angeletti CA; Basolo F; Pingitore R; Bevilacqua G
J Pathol; 1994 Sep; 174(1):23-31. PubMed ID: 7965400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
